Innovent Biologics
To develop and commercialize high-quality biopharmaceuticals that are affordable to ordinary people
846 employees · est. 2011 · Suzhou, China
Oryzon Genomics SA is the older company (2011 vs 2000); Innovent Biologics is the larger of the two.
Side-by-Side Comparison
| Metric | Innovent Biologics | Oryzon Genomics SA |
|---|---|---|
| Founded | ||
| Founded | 2011 | 2000 older |
| Headquarters | ||
| Headquarters | Suzhou, China | Spain |
| Employees | ||
| Employees | 846 larger | 60 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Manufacturing | Not tracked yet |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | IPO |
| Total Funding | ||
| Total Funding | Not tracked yet | $193.19M |
| Funding Rounds | ||
| Funding Rounds | 6 | 21 |
| Services | ||
| Services | Not tracked yet | Development of personalized therapeutics, Epigenetic biomarker identification, Innovation in cancer and CNS disorder treatments, Patent portfolio management |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with cancer, Patients with CNS disorders, Healthcare providers, Biopharmaceutical investors |
| Taxonomy | ||
| Taxonomy | Biopharmaceuticals, Monoclonal Antibodies, Biosimilars, Drug Development, Cancer Treatment, Metabolic Diseases, Autoimmune Diseases, Biologics Manufacturing, Clinical Trials, Commercialization, R&D, Global Standard Compliance, Funding, Strategic Partnerships, International Market Expansion | Personalized Medicine, Epigenetics, CNS Disorders, Oncology, Biopharmaceuticals, LSD1 Inhibitors, Biomarker Identification, Target Validation, Acute Myeloid Leukemia, Small Cell Lung Cancer, Phase II Clinical Trials, Psychiatric Diseases, Neurodegeneration, Drug Discovery, Therapeutic Development |
| Website | ||
| Website | innoventbio.com | oryzon.com |
About Innovent Biologics
Innovent Biologics is a biopharmaceutical company established in 2011 with a commitment to develop and commercialize high-quality innovative medicines. The company focuses on treating major diseases such as cancer. It was publicly listed on the Main Board of the Stock Exchange of Hong Kong Limited w...
About Oryzon Genomics SA
Oryzon Genomics SA, founded in 2000 and headquartered in Spain, is a clinical stage biopharmaceutical leader in the development of epigenetics-based therapeutics, with an emphasis on personalized medicine for CNS disorders and oncology. Known for its slogan, "Pioneering personalized medicine in epig...
We will tell you when either one moves
BounceWatch watches Innovent Biologics and Oryzon Genomics SA for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Innovent Biologics and Oryzon Genomics SA — by email.
Frequently Asked Questions
Compare Innovent Biologics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Innovent Biologics on 20 Dec 2024, and Oryzon Genomics SA on 26 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
